Page last updated: 2024-08-24

gemcitabine and Neoplasms, Nerve Sheath

gemcitabine has been researched along with Neoplasms, Nerve Sheath in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergsland, CH; Bruun, J; Danielsen, SA; Eilertsen, IA; Høland, M; Kallioniemi, O; Kolberg, M; Lothe, RA; Mpindi, JP; Murumägi, A	1

Other Studies

1 other study(ies) available for gemcitabine and Neoplasms, Nerve Sheath

Article	Year
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors. Molecular oncology, 2017, Volume: 11, Issue:9 Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Clinical Trials as Topic; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Nerve Sheath Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Reproducibility of Results; Ribonucleoside Diphosphate Reductase; Tumor Suppressor Proteins	2017

Article

Year

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.

Molecular oncology, 2017, Volume: 11, Issue:9

Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Clinical Trials as Topic; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Nerve Sheath Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Reproducibility of Results; Ribonucleoside Diphosphate Reductase; Tumor Suppressor Proteins

2017